Liver Cirrhosis Current Events | Liver Cirrhosis News | 2
|
| Page
2 of
26 |
514 Results |
|
|
|
Sort By:
Page Views | Date |
Mayo Clinic's new imaging technology accurately identifies a broad spectrum of liver disease
A new study shows that an imaging technology developed by Mayo Clinic researchers can identify liver fibrosis with high accuracy and help eliminate the need for liver biopsies. Liver fibrosis is a common condition that can lead to incurable cirrhosis if not treated in time. view more (2008-11-03)
Melatonin may be served as a potential anti-fibrotic drug
In China, the incidence of liver cirrhosis is still high. Liver cirrhosis results from fibrosis. If treated properly at fibrosis stage, cirrhosis can be prevented. view more (2009-03-31)
Can liver cirrhosis be partially cured?
The diffusion of hepatitis C virus infection worldwide is astonishing. Liver cirrhosis is present in at least 10-20% of these infected patients, with highly increasing health care and emotional costs. view more (2007-10-11)
Noninvasive tests for cirrhosis may help to avoid liver biopsy
Newer ultrasound and magnetic resonance (MR) imaging tests yield encouraging initial results in diagnosing fibrosis (scarring) and cirrhosis of the liver, according to three studies in the October issue of the journal Clinical Gastroenterology and Hepatology. view more (2007-10-02)
How to select anti-hepatitis B virus agents for drug-resistance patients?
HBV infection may lead to acute liver disease, chronic active hepatitis, liver cirrhosis, and hepatocellular carcinoma. Over 350 million people worldwide are estimated to be infected chronically by HBV and are therefore at risk of liver failure, cirrhosis, or hepatocellular carcinoma. view more (2008-09-25)
Test predicts risk of liver scarring after transplant, study shows
An estimated 20 percent of people with chronic hepatitis C who receive a liver transplant will develop advanced cirrhosis, scarring of the new organ severe enough to impair its ability to function normally within five years of transplantation. view more (2005-10-06)
The use of stem cells in regenerative medicine may also be detrimental for health
The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the University of Granada and University of León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats... view more... (2009-11-13)
Researchers show that fibrosis can be stopped, cured and reversed
University of California, San Diego researchers have proven in animal studies that fibrosis in the liver can be not only stopped, but reversed. view more (2007-12-27)
New research may lead to earlier diagnosis and treatment of primary biliary cirrhosis in families
Mayo Clinic researchers have found that first-degree relatives (i.e., parents, siblings, children) of patients with primary biliary cirrhosis (PBC) are more likely to have the biomarker of the disease in their blood. view more (2007-09-11)
Cure for hepatitis C announced by VCU researcher
The use of peginterferon alone, or in combination with ribavirin, points to a cure for hepatitis C, the leading cause of cirrhosis, liver cancer and the need for liver transplant, a Virginia Commonwealth University researcher said today. view more (2007-05-22)
New Mayo Clinic MRI technology enables noninvasive liver diagnoses
Two recent Mayo Clinic studies have found that magnetic resonance elastography (MRE), a new imaging technique invented at Mayo Clinic, is an accurate tool for non-invasive diagnosis of liver diseases. view more (2007-05-23)
For Patients With Cirrhosis, Inflammation May Be Common Thread Behind Nervous And Heart Rhythm Problems
Liver cirrhosis is the seventh leading cause of death in the United States, taking 25,000 lives per year. view more (2009-02-10)
If the diabetes has a direct carcinogenetic effect?
The association of DM2 with solid tumors, and particularly with HCC, has been long suspected and several studies have reported increased mortality rates for neoplastic diseases in patients with DM2. view more (2008-10-29)
Losing a bit of weight and doing some exercise slows progression of chronic liver disease
Losing weight and exercising regularly slows progression of chronic liver disease in those who are overweight, indicates a study in Gut. Being overweight is bad for the liver. And non-alcoholic fatty liver is increasingly being diagnosed in those who are overweight, diabetic, or who have insulin resistance syndrome, a precursor to diabetes.... view more... (2004-02-11)
New test helps identify hepatitis C patients at high risk of developing cirrhosis
A researcher at the Stanford University School of Medicine has helped confirm the reliability of a new test for liver disease that is ushering in the long-promised era of personalized medicine based on each individual's genetic makeup. view more (2007-04-27)
New test helps identify hepatitis C patients at high risk of developing cirrhosis
A researcher at the Stanford University School of Medicine has helped confirm the reliability of a new test for liver disease that is ushering in the long-promised era of personalized medicine based on each individual's genetic makeup. view more (2007-04-30)
Incidence of Fatty Liver Disease rises as obesity in children increases
Indiana University School of Medicine researchers are taking a closer look at a disease whose incidence is rising as obesity in children increases. Non-Alcoholic Steatohepatitis, more popularly known as Fatty Liver Disease, occurs in approximately 15% of obese children. view more (2007-03-16)
Is extra-corporal liver support with prometheus safe in patients with end-stage liver disease?
Patients with end-stage liver disease would benefit from liver supportive liver therapy while waiting for stabilization of hepatic functions or to enable bridging to liver transplantation. view more (2008-05-21)
Protective action of a molecule in inflammatory processes discovered
Henar Hevia Pérez, researcher in the area of Genic Therapy and Hepatology at the Applied Medicine Research Centre (CIMA)of the University of Navarra, has discovered the protective role of the methylthioadenosine (MTA) molecule in an in vivo inflammation model. view more (2006-04-27)
Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer
As the incidence of liver cancer continues to grow-- fueled in large part, by rising rates of hepatitis C infections - so too does the need for tests to help diagnose the disease at an earlier stage. view more (2008-01-15)
|
|
| Page
2 of
26 |
514 Results |
|
|
|
Sort By:
Page Views | Date |
|
